Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230282
Status:
COMPLETED
Last Update Posted:
2014-10-06
First Post:
2005-09-28
Brief Title:
Phase 2 Fludarabine Cytoxan and FCCAM Alemtuzumab in Untreated B-Cell Chronic Lymphocytic Leukemia
Sponsor:
Steven E Coutre
Organization:
Stanford University
Organization Data
Organization:
Stanford University
Class:
OTHER
Study ID:
IRB-13053
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Steven E Coutre
Lead Sponsor Class:
OTHER
Responsible Party:
Steven E Coutre
Responsible Party Title:
Associate Professor of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Stanford University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |